328 related articles for article (PubMed ID: 21841783)
1. Pathway to diabetes through attenuation of pancreatic beta cell glycosylation and glucose transport.
Ohtsubo K; Chen MZ; Olefsky JM; Marth JD
Nat Med; 2011 Aug; 17(9):1067-75. PubMed ID: 21841783
[TBL] [Abstract][Full Text] [Related]
2. HCV affects K
Niu B; Ma L; Yao L; Zhang Y; Su H
Endocrine; 2024 May; 84(2):427-440. PubMed ID: 37962815
[TBL] [Abstract][Full Text] [Related]
3. Dietary copper supplementation restores β-cell function of Cohen diabetic rats: a link between mitochondrial function and glucose-stimulated insulin secretion.
Weksler-Zangen S; Jörns A; Tarsi-Chen L; Vernea F; Aharon-Hananel G; Saada A; Lenzen S; Raz I
Am J Physiol Endocrinol Metab; 2013 May; 304(10):E1023-34. PubMed ID: 23512809
[TBL] [Abstract][Full Text] [Related]
4. N-Glycosylation modulates the membrane sub-domain distribution and activity of glucose transporter 2 in pancreatic beta cells.
Ohtsubo K; Takamatsu S; Gao C; Korekane H; Kurosawa TM; Taniguchi N
Biochem Biophys Res Commun; 2013 May; 434(2):346-51. PubMed ID: 23548572
[TBL] [Abstract][Full Text] [Related]
5. Metallothionein 1 negatively regulates glucose-stimulated insulin secretion and is differentially expressed in conditions of beta cell compensation and failure in mice and humans.
Bensellam M; Shi YC; Chan JY; Laybutt DR; Chae H; Abou-Samra M; Pappas EG; Thomas HE; Gilon P; Jonas JC
Diabetologia; 2019 Dec; 62(12):2273-2286. PubMed ID: 31624901
[TBL] [Abstract][Full Text] [Related]
6. Plasma nonesterified Fatty Acid intolerance and hyperglycemia are associated with intravenous lipid-induced impairment of insulin sensitivity and disposition index.
Carpentier AC; Bourbonnais A; Frisch F; Giacca A; Lewis GF
J Clin Endocrinol Metab; 2010 Mar; 95(3):1256-64. PubMed ID: 20097711
[TBL] [Abstract][Full Text] [Related]
7. Induction of receptor for advanced glycation end products by insufficient leptin action triggers pancreatic β-cell failure in type 2 diabetes.
Han D; Yamamoto Y; Munesue S; Motoyoshi S; Saito H; Win MT; Watanabe T; Tsuneyama K; Yamamoto H
Genes Cells; 2013 Apr; 18(4):302-14. PubMed ID: 23410183
[TBL] [Abstract][Full Text] [Related]
8. Computational modeling of glucose transport in pancreatic β-cells identifies metabolic thresholds and therapeutic targets in diabetes.
Luni C; Marth JD; Doyle FJ
PLoS One; 2012; 7(12):e53130. PubMed ID: 23300881
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of GPR40 in pancreatic beta-cells augments glucose-stimulated insulin secretion and improves glucose tolerance in normal and diabetic mice.
Nagasumi K; Esaki R; Iwachidow K; Yasuhara Y; Ogi K; Tanaka H; Nakata M; Yano T; Shimakawa K; Taketomi S; Takeuchi K; Odaka H; Kaisho Y
Diabetes; 2009 May; 58(5):1067-76. PubMed ID: 19401434
[TBL] [Abstract][Full Text] [Related]
10. Deteriorated high-fat diet-induced diabetes caused by pancreatic β-cell-specific overexpression of Reg3β gene in mice.
Xiong X; Li Q; Cui W; Gao ZH; Liu JL
Endocrine; 2016 Nov; 54(2):360-370. PubMed ID: 27259509
[TBL] [Abstract][Full Text] [Related]
11. TLR4 is required for the obesity-induced pancreatic beta cell dysfunction.
Li J; Chen L; Zhang Y; Zhang WJ; Xu W; Qin Y; Xu J; Zou D
Acta Biochim Biophys Sin (Shanghai); 2013 Dec; 45(12):1030-8. PubMed ID: 23985305
[TBL] [Abstract][Full Text] [Related]
12. Dietary and genetic control of glucose transporter 2 glycosylation promotes insulin secretion in suppressing diabetes.
Ohtsubo K; Takamatsu S; Minowa MT; Yoshida A; Takeuchi M; Marth JD
Cell; 2005 Dec; 123(7):1307-21. PubMed ID: 16377570
[TBL] [Abstract][Full Text] [Related]
13. Palmitate-Induced Insulin Hypersecretion and Later Secretory Decline Associated with Changes in Protein Expression Patterns in Human Pancreatic Islets.
Groebe K; Cen J; Schvartz D; Sargsyan E; Chowdhury A; Roomp K; Schneider R; Alderborn A; Sanchez JC; Bergsten P
J Proteome Res; 2018 Nov; 17(11):3824-3836. PubMed ID: 30183308
[TBL] [Abstract][Full Text] [Related]
14. Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes.
Lewis GF; Carpentier A; Adeli K; Giacca A
Endocr Rev; 2002 Apr; 23(2):201-29. PubMed ID: 11943743
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of Id1 augments insulin secretion and protects against high-fat diet-induced glucose intolerance.
Akerfeldt MC; Laybutt DR
Diabetes; 2011 Oct; 60(10):2506-14. PubMed ID: 21940780
[TBL] [Abstract][Full Text] [Related]
16. Novel proapoptotic effect of hepatocyte growth factor: synergy with palmitate to cause pancreatic {beta}-cell apoptosis.
González-Pertusa JA; Dubé J; Valle SR; Rosa TC; Takane KK; Mellado-Gil JM; Perdomo G; Vasavada RC; García-Ocaña A
Endocrinology; 2010 Apr; 151(4):1487-98. PubMed ID: 20176723
[TBL] [Abstract][Full Text] [Related]
17. Early and rapid development of insulin resistance, islet dysfunction and glucose intolerance after high-fat feeding in mice overexpressing phosphodiesterase 3B.
Walz HA; Härndahl L; Wierup N; Zmuda-Trzebiatowska E; Svennelid F; Manganiello VC; Ploug T; Sundler F; Degerman E; Ahrén B; Holst LS
J Endocrinol; 2006 Jun; 189(3):629-41. PubMed ID: 16731793
[TBL] [Abstract][Full Text] [Related]
18. VEGF-B ablation in pancreatic β-cells upregulates insulin expression without affecting glucose homeostasis or islet lipid uptake.
Ning FC; Jensen N; Mi J; Lindström W; Balan M; Muhl L; Eriksson U; Nilsson I; Nyqvist D
Sci Rep; 2020 Jan; 10(1):923. PubMed ID: 31969592
[TBL] [Abstract][Full Text] [Related]
19. Experimental evidence for the use of CCR2 antagonists in the treatment of type 2 diabetes.
Sullivan TJ; Miao Z; Zhao BN; Ertl LS; Wang Y; Krasinski A; Walters MJ; Powers JP; Dairaghi DJ; Baumgart T; Seitz LC; Berahovich RD; Schall TJ; Jaen JC
Metabolism; 2013 Nov; 62(11):1623-32. PubMed ID: 23953944
[TBL] [Abstract][Full Text] [Related]
20. GPR120 protects lipotoxicity-induced pancreatic β-cell dysfunction through regulation of PDX1 expression and inhibition of islet inflammation.
Wang Y; Xie T; Zhang D; Leung PS
Clin Sci (Lond); 2019 Jan; 133(1):101-116. PubMed ID: 30523046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
